These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214 [TBL] [Abstract][Full Text] [Related]
28. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients. Schober T; Framke T; Kreipe H; Schulz TF; Großhennig A; Hussein K; Baumann U; Pape L; Schubert S; Wingen AM; Jack T; Koch A; Klein C; Maecker-Kolhoff B Transplantation; 2013 Jan; 95(1):240-6. PubMed ID: 23222898 [TBL] [Abstract][Full Text] [Related]
30. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder. Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104 [TBL] [Abstract][Full Text] [Related]
31. Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders. Cho YU; Chi HS; Jang S; Park SH; Park CJ Am J Clin Pathol; 2014 Feb; 141(2):268-74. PubMed ID: 24436276 [TBL] [Abstract][Full Text] [Related]
32. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders. Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912 [TBL] [Abstract][Full Text] [Related]
35. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014. Seçkin D G Ital Dermatol Venereol; 2014 Aug; 149(4):401-8. PubMed ID: 25068227 [TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment. Overkamp M; Granai M; Bonzheim I; Steinhilber J; Schittenhelm J; Bethge W; Quintanilla-Martinez L; Fend F; Federmann B Virchows Arch; 2021 Jun; 478(6):1135-1148. PubMed ID: 33324999 [TBL] [Abstract][Full Text] [Related]
37. How I treat posttransplant lymphoproliferative disorder. Amengual JE; Pro B Blood; 2023 Oct; 142(17):1426-1437. PubMed ID: 37540819 [TBL] [Abstract][Full Text] [Related]
38. Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients. Karuturi M; Shah N; Frank D; Fasan O; Reshef R; Ahya VN; Bromberg M; Faust T; Goral S; Schuster SJ; Stadtmauer EA; Tsai DE Transpl Int; 2013 Jun; 26(6):616-22. PubMed ID: 23551167 [TBL] [Abstract][Full Text] [Related]
39. Posttransplant lymphoproliferative disorder of the central nervous system. Kempf C; Tinguely M; Rushing EJ Pathobiology; 2013; 80(6):310-8. PubMed ID: 24013167 [TBL] [Abstract][Full Text] [Related]
40. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab. Loomis R; Carbone R; Reiss M; Lacy J Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]